Home/Filings/4/0001209191-18-041236
4//SEC Filing

Masamune Hiroko 4

Accession 0001209191-18-041236

CIK 0001607678other

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 5:25 PM ET

Size

7.3 KB

Accession

0001209191-18-041236

Insider Transaction Report

Form 4
Period: 2018-07-01
Masamune Hiroko
Chief Development Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-07-01+42,00042,000 total
    Exercise: $9.49From: 2019-07-01Exp: 2028-07-01Common Stock (42,000 underlying)
  • Award

    Common Stock, par value $0.00001 per share

    2018-07-01+15,000111,197 total
Footnotes (2)
  • [F1]Represents a restricted stock unit award ("RSU") of common stock under the Issuer's 2014 Equity Incentive Plan. One-third of the shares subject to the RSU shall vest on each one year anniversary of the grant date of the award.
  • [F2]One-third of the shares subject to the option will vest on each one year anniversary of the grant date.

Issuer

Viking Therapeutics, Inc.

CIK 0001607678

Entity typeother

Related Parties

1
  • filerCIK 0001745341

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 5:25 PM ET
Size
7.3 KB